Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Open full size image KEY POINTS All patients with cancer should be evaluated for the presence and risk of developing arrhythmias because these can significantly complicate treatments and outcomes The intake should include preexisting atrial fibrillation, QTc prolongation, and cardiac…

Open full size image KEY POINTS Patients with cancer account for more than 20% of all newly diagnosed cases of venous thromboembolic events (VTEs); they are six times more likely to develop VTEs Risk factors for VTE in patients with…

You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here

Open full size image KEY POINTS All patients should undergo screening for preexisting/concomitant cardiovascular (CV) risk factors, cancer-specific risks for cardiomyopathy, and previous cancer therapy-related risk factors for cardiomyopathy before initiation of cancer treatment. Cardiomyopathy or heart failure (CM/HF) can…

Open full size image KEY POINTS Cardiovascular risks depend on traditional risk factors, cancer type, and type of surgical procedures. Assessment of left ventricular (LV) function should be performed preoperatively in patients who have received potentially cardiotoxic chemotherapies, including but…

Open full size image KEY POINTS Hematopoietic stem cell transplantation (HSCT) involves the infusion of multipotent hematopoietic stem cells, usually derived from the bone marrow, peripheral blood, or umbilical cord, and using cells from either the patient him-/herself (autologous), a…

Open full size image KEY POINTS Radiation therapy can lead to various forms of cardiovascular disease, including cardiomyopathy, heart failure, coronary artery disease, valvular heart disease, pericardial disease, and autonomic dysfunction. Dose sparing is the single most important preventive strategy,…

Open full size image KEY POINTS Cancer therapies can be associated with a broad range of cardiovascular toxicities The three most important cardiovascular toxicities in terms of reported incidence and severity are 1) cardiomyopathy and heart failure, 2) vascular toxicities…

You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here

Open full size image KEY POINTS The cardio-oncology clinic covers all cardiovascular aspects of patients with cancer, including tumors that involve the heart and vasculature, cancer therapies that affect the heart and vasculature, and cardiovascular diseases in patients with cancer.…